MedTrace Logo

Prediction and Prevention of Preeclampsia by First Trimester Ultrasound

NCT01195441 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 602

Last updated 2017-02-13

No results posted yet for this study

Summary

The purpose of this study is to determine whether the Fetal Medicine Foundation algorithm for individual risk calculation for preeclampsia (PE) and pregnancy induced hypertension (PIH) is suitable to identify women in high risk of developing these diseases in a Norwegian population.

Conditions

Sponsors & Collaborators

  • St. Olavs Hospital

    collaborator OTHER

  • Norwegian University of Science and Technology

    lead OTHER

Principal Investigators

  • Ragnhild B Skraastad, Cand Med · LBK, NTNU, National Center for Fetal Medicine

  • Kjell Aa Salvesen, Dr Med · LBK, NTNU, National Center for Fetal Medicine

  • Harm-Gerd K Blaas, Dr Med · LBK, NTNU, National Center for Fetal Medicine

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2012-11-30
Completion
2013-10-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01195441 on ClinicalTrials.gov